INDUCTION OF CYTOTOXIC T LYMPHOCYTES IN VITRO

细胞毒性 T 淋巴细胞的体外诱导

• 批准号: 7724889
• 负责人: BORIS MINEV
• 金额: $ 0.18万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-12-01 至 2008-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7724889
• 关键词: Breast; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; In Vitro; Institution; Lymphocyte; Malignant neoplasm of lung; Patients; Peptides; Prostate; Research; Research Personnel; Resources; Source; Tumor Antigens; United States National Institutes of Health; cytotoxic; melanoma; peripheral blood

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine whether patients with melanoma, prostate, breast and lung cancer possess lymphocytes able to react with peptides, derived from tumor-associated antigens. Lymphocytes will be isolated from patients' peripheral blood.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 确定黑色素瘤，前列腺，乳腺癌和肺癌患者是否具有能够与肿瘤相关抗原衍生的肽反应的淋巴细胞。将从患者的外周血中分离出淋巴细胞。